Neogen Corporation shares jumped 23% after solid Q1 results and a new cost-cutting plan that trims 10% of its workforce, signaling a focused turnaround under ...

Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast Track status and solid cash ...

Novavax faces pressure from a major shareholder Shah Capital to explore a sale as it struggles with weak revenue, poor execution, and fading relevance post-COVID-19. ...

DocGo buys virtual care platform SteadyMD in an all-cash deal, boosting its digital health reach. The move excites investors as DocGo gains growth, profit potential, ...